SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹10 Cr | ₹8.57 Cr | ₹7.09 Cr | ₹6.83 Cr | ₹6.40 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SAKAR HEALTHCARE ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹10 Cr |
Mar2023 | ₹8.57 Cr |
Mar2022 | ₹7.09 Cr |
Mar2021 | ₹6.83 Cr |
Mar2020 | ₹6.40 Cr |
How is Deferred Tax Assets / Liabilities of SAKAR HEALTHCARE Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹10 Cr | 16.94 | |
Mar2023 | ₹8.57 Cr | 20.87 | |
Mar2022 | ₹7.09 Cr | 3.88 | |
Mar2021 | ₹6.83 Cr | 6.75 | |
Mar2020 | ₹6.40 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹700.3 Cr | -2.6% | 18.3% | -4.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | -2.6% |
18.3% |
-4.7% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses